Affiliation:
1. Johns Hopkins School of Medicine Baltimore Maryland USA
2. Johns Hopkins School of Medicine, Cancer Ecology Center The James Brady Urological Institute Baltimore Maryland USA
3. Cellular and Molecular Medicine Program Johns Hopkins School of Medicine Baltimore Maryland USA
4. Pharmacology and Molecular Sciences Program Johns Hopkins School of Medicine Baltimore Maryland USA
Abstract
AbstractBackgroundLipid reprogramming is a known mechanism to increase the energetic demands of proliferating cancer cells to drive and support tumorigenesis and progression. Elevated lipid droplets (LDs) are a well‐known alteration of lipid reprogramming in many cancers, including prostate cancer (PCa), and are associated with high tumor aggressiveness as well as therapy resistance. The mechanism of LD accumulation and specific LD functions are still not well understood; however, it has been shown that LDs can form as a protective mechanism against lipotoxicity and lipid peroxidation in the cell.MethodsThis study investigated the significance of LDs in PCa. This was done by staining, imaging, image quantification, and flow cytometry analysis of LDs in PCa cells. Additionally, lipidomics and metabolomics experiments were performed to assess the difference of metabolites and lipids in control and treatment surviving cancer cells. Lastly, to assess clinical significance, multiple publicly available datasets were mined for LD‐related data.ResultsOur study demonstrated that prostate and breast cancer cells that survive 72 h of chemotherapy treatment have elevated LDs. These LDs formed in tandem with elevated reactive oxygen species levels to sequester damaged and excess lipids created by oxidative stress, which promoted cell survival. Additionally, by inhibiting diacylglycerol O‐acyltransferase 1 (DGAT1) (which catalyzes triglyceride synthesis into LDs) and treating with chemotherapy simultaneously, we were able to decrease the overall amount of LDs and increase cancer cell death compared to treating with chemotherapy alone.ConclusionsOverall, our study proposes a potential combination therapy of DGAT1 inhibitors and chemotherapy to increase cancer cell death.
Reference36 articles.
1. American Cancer Society. Cancer Facts and Figures 2023. 2023.
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. American Cancer Society. Key Statistics for Prostate Cancer—Prostate Cancer Facts.2023. Accessed February 7 2023.https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html
4. Convergent Evolution, Evolving Evolvability, and the Origins of Lethal Cancer
5. Hallmarks of Cancer: The Next Generation
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献